English

Quality matters: Improving the quality of biological resources

 

>> Recorded sessions available here <<

 

Introduction

High quality biological resources are critical pre-requisite for research and clinical diagnosis.

Evidence-based practices in biological resources research have been promoted by research institutions and programs such as the US NCI Biospecimen Research Network (BRN), and SPIDIA, a consortium funded by the European Union. These projects and programs identified major questions of methodology and pre-analytical variables that could influence the quality of samples. They also resulted in significant findings that should promote best practices for biological resources use in clinical and basic research programs.

The aim of this meeting is to disseminate evidence-based practices, and promote integration of the results of such studies into research and clinical practice.

Attendees

Researchers from European and Asian biobanks.

The meeting dealt with quality control of

  • Tissue samples
  • Brain samples
  • Tumors
  • Liquid samples
  • Nucleic acids
  • Proteins
  • Cell cultures

Invited speakers

BECKER Karl Friedrich 
Universität München-Institut für Pathologie, Germany
BJÖRKMAN Jens TATAA Biocenter - Göteborg, Sweden
BONNET Jacques
Inserm U916, Bordeaux, France
CLEMENT Bruno
Inserm UMR 991, Rennes, France
DAGHER Georges Inserm US013, Paris, France
DAIDONE Maria Grazia Instituto Tumori, Milan, Italy
DUYCKAERTS Charles
Inserm U106, Paris, France
ERB Gilles Roche diagnostics, France
GERLIER Denis CIRI, Lyon
HASLACHER Helmuth BBMRI, Wien, Austria
HOFMAN Paul
Inserm1081, CHU Nice, France
HUPPETZ Berthold Medical Graz University, Austria
JUNOT Christophe CEA, Paris, France
LAVITRANO Maria Luisa Milan Bicocca Univ, Italy
LAWLOR Rita T. ARC-NET Research Centre, Italy
 LITTON Jan-Eric
Karolinska Institute - Sweden
LOIBNER Martina
Medical University of Graz, Austria
LUNDEBERG Joakim Karolinska Institute - Sweden
MATHIESON William
Integrated BioBank of Luxembourg, Luxembourg
METSPALU Andres
Estonian Genome Center, Estonia
MOORE Helen National Cancer Institute, USA
MORENTE Manuel
Spanish National Cancer, Spain
OELMUELLER Uwe 
QIAGEN, Germany
OLLIER Bill 
CIGMR, UK
PARODI Barbara 
IRCCS AOU San Martino – IST, Genoa, Italy
RUAN Lianliang Shanghai Clinical Research Center, China
STANTA Giorgio
Trieste University, Italy
TURANO Paola
Magnetic Resonance Centre, Florence, Italy
VACHER Coralie
Illumina,UK
VAUGHT Jim
ISBER, USA
WANG Peng
Beijing Capital University, China
WATSON Peter
BC Cancer Agency, Vancouver Island Center, Canada
WICHMAN Erich
Helmholtz Zentrum Muenchen, Germany
YUILLE Martin
CIGMR, UK
ZAOMI Myriam Inserm US013, Paris, France
ZATLOUKAL Kurt     
Medical Graz University, Austria

The construction and operation of national biobanking infrastructures

Georges DAGHER     
The French National infrastructure for biobanking
Maria Luisa LAVITRANO
The Italian National infrastructure for biobanking
Manuel MORENTE
The Spanish National infrastructure for biobanking
Kurt ZATLOUKAL
The Austrian National infrastructure for biobanking

Meeting organised in partnership with

     

       

 
 
 
 
 
 
 
 
 
 
 
 

 

 

Contact

BIOBANQUES, INSERM US013

Hôpital de la Salpétrière

47, bd de l'Hôpital - 75651 Paris Cedex 13

 - Plan d'accès - Access map -